CareGroup and Cerner Multum Reduce Adverse Drug Events.

Business Editors/Health and Medical Writers

KANSAS CITY, Mo.--(BW HealthWire)--June 1, 2000

Cerner Corporation (Nasdaq:CERN), the world's leading clinical healthcare information technology company, is pleased to announce that CareGroup Healthcare System, a leader and advocate for information technology and patient safety, has chosen Cerner Multum content and patient-specific drug information services as strategic components of its patient safety initiatives.

CareGroup Healthcare System is a renowned integrated delivery network of six hospitals in eastern Massachusetts, including Beth Israel Deaconess Medical Center, a Harvard Medical School-affiliated teaching hospital, and New England Baptist Hospital, a teaching affiliate of Tufts University School of Medicine. CareGroup is also associated with the Picker Institute, the world leader in patient satisfaction and healthcare quality measurement.

"At CareGroup Healthcare System, we invest in advanced knowledge tools that increase the quality of clinical decision-making, enhance knowledge transfer between clinicians, augment the medical training of students and residents and empower consumers to serve as active agents in their pursuit of health," said John D. Halamka, M.D., Chief Information Officer of CareGroup. "We utilize Multum content as an education and patient safety tool for consumers on our healthcare system's web site and provide more sophisticated Multum drug information for clinicians to increase patient safety and reduce adverse drug events and medical errors." Cerner Multum's extensive, ongoing global research efforts yield the company's flagship product, MediSource(TM), which provides the most comprehensive patient-specific drug information available in the world. Vital Multum functionality includes a database of drugs and interaction points as well as proper dosing information based on patient-specific data.

A 1999 study by the Institute of Medicine estimated that up to 98,000 people die annually due to medical errors. Furthermore, new data on the prevalence of ADEs (Adverse Drug Events) has forced the government, healthcare community and consumers to search for new answers to this complex problem. According to research conducted by David W. Bates, Chairman of General Internal Medicine at Brigham and Women's Hospital and a Harvard faculty member, healthcare facilities experience an average of seven medical incidents per 100 patients and each of these incidents costs the healthcare system $5,000. Based upon this research, organizations that have 20,000 hospitalizations per year could save more than $1 million with Cerner Multum.

"We and our patients have derived significant benefits from Cerner Multum," said Halamka. "The products and services have exceeded our expectations and enhanced the quality of care we deliver to our communities. Our use of the electronic medical record and integrated Multum services and content equips clinicians and consumers with the appropriate tools to ensure optimal care and the highest patient safety standards."

"Cerner Multum's extensive body of executable knowledge has significantly enhanced Cerner's industry-leading clinical decision support capabilities, allowing health systems to provide the best quality care and avoid costly adverse drug events," said Neal Patterson, Chairman and Chief Executive Officer for Cerner Corporation. "CareGroup is a leader in education, research and patient safety. CareGroup's decision to utilize Cerner Multum as the foundation of its efforts to help save patient lives is further proof of the Cerner commitment to make healthcare smarter, safer and more efficient." Cerner Multum, Inc., a Cerner company based in Denver, Colorado, was founded in 1992 to develop innovative and cost-effective solutions for the growing problem of ADEs.

CareGroup, the healthcare system of Beth Israel Deaconess Medical Center, Mount Auburn Hospital, New England Baptist Hospital, Deaconess-Waltham Hospital, Deaconess-Nashoba Hospital, and Deaconess-Glover Hospital, is a system of world-renowned academic medical centers and outstanding community hospitals that are dedicated to providing the best quality care and services to patients in a highly personalized manner.

Cerner Corporation (www.cerner.com) is a leading supplier of clinical and management information and knowledge systems to more than 1,000 healthcare organizations worldwide. Cerner's mission is to connect the appropriate persons, knowledge, and resources at the appropriate time and location to achieve the optimal health outcome. Cerner's vision of proactive healthcare management drives innovation today, while creating a foundation for tomorrow's healthy populations. With HNA Millennium(R), Cerner has developed a comprehensive suite of solutions that promote personal and community health management by providing the link between individuals and the care process. HNA Millennium applications work on a cohesive platform that is open, intelligent and scalable. This allows for communication, access, and data to be shared throughout the healthcare system. The following is a trademark of Cerner: MediSource.

This release may contain forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "should," "will be," "intended," "continue," "believe," "may," "expect," "hope," "anticipate," "goal," "forecast" and similar expressions are intended to identify such forward-looking statement. Factors that could cause or contribute to such differences include, but are not limited to: variations in the Company's quarterly operating results, volatility of the Company's stock price, market risk of investments, changes in the healthcare industry, significant competition, the Company's proprietary technology may be subjected to infringement claims or may be infringed upon, regulation of the Company's software by the U.S. Food and Drug Administration or other government regulation, the possibility of product-related liabilities, possible failures or defects in the performance of the Company's software, the possibility that the Company's anti-takeover defenses could delay or prevent an acquisition of the Company, and uncertainties related to the Year 2000. Additional discussion of these and other factors affecting the company's business is contained in the company's periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.